Science Inc.
- Industry
- Venture Capital
- Founded Year
- 2011
- Headquarters
- Los Angeles, USA
- Employee Count
- 0
Key People
- Michael Jones - Founder and CEO
- Greg Gilman - Co-Founder and Executive Chair
- Tom Dare - Partner
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced entrepreneurs with successful track records in various sectors.
Michael Jones, the founder and CEO, has a history of successful ventures, including Dollar Shave Club. Greg Gilman and Tom Dare bring extensive experience in entrepreneurship and investment, contributing to a robust leadership team.
- Clinical Need
-
Aspect: Decent
Summary: The company's focus on consumer products addresses existing market demands.
Science Inc. invests in consumer-focused startups, which meet existing market needs but may not address critical unmet needs in the MedTech sector.
- Competition
-
Aspect: Somewhat crowded
Summary: The venture capital and startup studio space is competitive.
With many players in the venture capital and startup incubation space, Science Inc. must differentiate itself to attract top-tier startups and investors.
- Technical Challenge
-
Aspect: Low-minimal Risk
Summary: The company's business model involves low technical risk.
As a startup studio and venture capital firm, Science Inc. primarily faces business and market challenges rather than technical ones.
- Patent
-
Aspect: None
Summary: The company does not hold patents.
Science Inc.'s focus is on investing in and supporting startups rather than developing proprietary technologies, making patents less relevant to its success.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
With investments from Tomorrow Ventures, Hearst Ventures, and Silver Lake Waterman, Science Inc. is well-capitalized to support its portfolio companies and operations.
- Regulatory
-
Aspect: Concept Stage
Summary: Regulatory considerations are minimal for the company's operations.
As a venture capital firm and startup studio, Science Inc. is not directly involved in product development or services that require regulatory approval.
Opportunity Rollup
- Odds of Success
- 3.75
- Peak Market Share
- 4.5
- Segment CAGR
- <em>Unknown</em>
- Market Segment
- <em>Unknown</em>
- Market Sub Segment
- <em>Unknown</em>
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.68 |
| 3 | 1.58 |
| 4 | 3.15 |
| 5 | 4.50 |
Key Takeaway
Science Inc. leverages a strong leadership team and substantial funding to support a diverse portfolio of startups, positioning itself well in the competitive venture capital landscape.